ReN-1826

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameReN-1826
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor inhibitors
TargetsNerve growth factor
Therapy Area/IndicationsUrinary Bladder NeoplasmsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Bristol
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReneuron Ltd
Active IndicationsN/A
Inactive IndicationsUrinary Bladder NeoplasmsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A